The front end and Rx need to be mutually beneficial
In today’s rapidly changing landscape, retail pharmacies are finding it tougher to survive, let alone thrive. Gross profit challenges are popping up everywhere — new competitors, generic drug price deflation, Medicare Part D plans pushing patients toward in-network or mail order pharmacies — and all of this before direct and indirect remuneration (DIR) fees. For
